Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
India bans condom adverts during primetime TV

Move is aimed at protecting children but campaigner warns it could undo decades of progress on sexual health.

Published
17 hours ago
From
The Guardian
Brazil Fights HIV Spike in Youths With Free Preventive Drug

The Brazilian Health Ministry is paying Gilead Sciences, the American manufacturer of the drug, about 75 cents a dose, a fraction of the price users pay in the United States, where PrEP sells for upward of $1,600 for a month’s supply.

Published
23 hours ago
From
New York Times
Australian Labor party commits to $53m plan to 'make HIV history'

People at high risk of HIV would be given cheap access to a breakthrough preventative medicine under a federal Labor plan to make Australia the first nation in the world to win the fight against the virus that causes AIDS. The opposition's $53 million plan would dramatically expand state trials of the drug PrEP until it is approved for a federal subsidy, increase funding for HIV peak bodies and tackle rising transmission rates in Aboriginal communities.

Published
11 December 2017
From
Sydney Morning Herald
Do HIV-Preventing Microbicides Have a Future in the Age of PrEP?

Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.

Published
11 December 2017
From
Poz
Undetectable = Untransmittable -- The Noise, the Joys and the Nuances

Let's focus on how U=U should impact our delivery of HIV care services to people living with HIV. Here are some "musts" on my list.

Published
11 December 2017
From
The Body
Setting the Standard: New prevention trials in the era of oral PrEP

There’s a lot going on in the world of HIV prevention research right now. One key issue is how participants might access oral PrEP as part of HIV prevention trials. It may seem simple: trial participants have the right to the highest standard of HIV prevention and care as part of participation. But the ethics, trial design issues and the mechanisms by which interventions are provided as standard of care are quite complex. Opinions differ and politics abound.

Published
08 December 2017
From
AVAC
Harm reduction approaches predicted to reduce rates of new hepatitis C infection for people who inject drugs

A combination of providing clean needles and syringes and offering safer oral therapy, such as methadone, reduced the predicted risk of becoming infected with hepatitis C virus by 71%. Providing both services to people who inject drugs was likely to be cost-effective and has the potential to be cost-saving in some parts of the UK, depending on the size of the local population of people who inject drugs and underlying rates of infection.

Published
08 December 2017
From
National Institute for Health Research
The Most Anti-Gay Corporate Policy in America Today

It’s time to end the anti-gay PrEP exclusion in America’s insurance industry. Some of the largest insurance companies in the nation exclude PrEP users who individually apply for life insurance, long-term care insurance or disability insurance.

Published
08 December 2017
From
GLAD
Medical circumcision efforts gained ground against new HIV infections, but not enough

Focused efforts to protect men and boys from HIV led to more than 14.5 million medical circumcision procedures globally between 2008 and 2016, enough to avert an estimated half million infections by 2030, according to a report released today.

Published
07 December 2017
From
Science Speaks
Fighting the HIV/AIDS Epidemic in the South

Despite national progress, the South is experiencing ‘an HIV hurricane.’

Published
06 December 2017
From
U.S. News & World Report
← First12345...399Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.